SCHEMBL27624488

SCHEMBL27624488

CCc1ccc(C(C)C=O)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.37
PTGS2 P35354 4/20 0.31
PTGS1 P23219 4/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
AKR1C3 P42330 2/20 0.31
AKR1C2 P52895 2/20 0.31
FABP2 P12104 1/20 0.31
TSHR P16473 1/20 0.31
AKR1C4 P17516 1/20 0.31
ADRA2B P18089 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2C P28335 1/20 0.31
DRD3 P35462 1/20 0.31
AKR1C1 Q04828 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27605507 0.86 SHBG (0.33) SHBGCHRM3TYRDPP4
SCHEMBL27530985 0.83 ALOX15 (0.34) AKR1C3AKR1C2TYR
SCHEMBL11951576 0.81 LMNA (0.38) SHBGPTGS2PTGS1MEN1KMT2A
SCHEMBL6180857 0.81 SHBG (0.39) SHBGAKR1C3AKR1C2
SCHEMBL27605597 0.79 SHBG (0.35) SHBG
SCHEMBL18942465 0.78 AKR1C3 (0.45) PTGS2PTGS1MEN1KMT2AAKR1C3
SCHEMBL16959739 0.78 SHBG (0.35) SHBGPTGS2PTGS1MEN1KMT2A
SCHEMBL27654459 0.77 ALOX15 (0.34) AKR1C3AKR1C2TSHRCYP1A2PSEN1
SCHEMBL27753244 0.76 APP (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10270727 0.76 ALDH1A1 (0.42) SHBGPTGS2PTGS1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100400041-C Diaminothiazoles useful as selective inhibitors of CDK4 HOFFMANN LA ROCHE (CH) 2008-07-09 CN disclosed
CN-1652780-A Diaminothiazoles used as CDK4 inhibitors HOFFMANN LA ROCHE (CH) 2005-08-10 CN disclosed